Skip to main content
. 2017 Jul 28;5(2):79–84. doi: 10.1055/s-0037-1603677

Table 1. Monitoring of clinical parameters during the study.

End point Baseline
( n  = 937)
Month 1
( n  = 821)
Month 3
( n  = 743)
Month 6
( n  = 698)
Month 9
( n  = 137)
Month 12
( n  = 106)
Pain at rest (VAS score) 55.9 ± 11.4 31.8 ± 9.7 24.9 ± 10.2 24.1 ± 9.1 25.3 ± 7.3 25.9 ± 6.9
Pain on movement (VAS score) 72.1 ± 9.8 48.3 ± 6.7 38.2 ± 7.7 37.9 ± 7.3 38.4 ± 6.5 38.9 ± 11.5
WOMAC score 56.8 ± 8.7 45.7 ± 7.9 27.6 ± 10.3 24.8 ± 8.8 N/A N/A.
Acetaminophen/NSAIDs use 48.8% 27.4% 19.4% 19.6% N/A N/A
Patient satisfaction
 Worsening (%) 2.4 3.2 4.8
 Unchanged (%) 9.3 8.9 9.6
 Improved (%) 88.3 87.9 85.6

Abbreviations: N/A, not available; NSAID, nonsteroidal anti-inflammatory drug; VAS, visual analog scale; WOMAC, Western Ontario McMasters University Osteoarthritis Index.